Results for tag: "Automated Cell Culture"

The automated cell culture market refers to the industry segment focused on the development and sale of systems and software that automate various aspects of cell culture in biotechnological applications. Cell culture is a cornerstone of biotechnology, used in research, bioprocessing, and the production of biological products such as vaccines, therapeutic proteins, and monoclonal antibodies. Automating cell culture processes can enhance standardization, reduce contamination risks, and increase throughput, thereby enabling high-efficiency production and research activities. Automated cell culture systems range from small benchtop devices for basic research to large-scale bioreactors used in commercial manufacturing. This market has seen steady expansion driven by advancements in biotechnology, the growing pharmaceutical industry, and the rising demand for personalized medicine. Several key players operate within the automated cell culture market, each contributing to the technology's advancement and adoption. Prominent companies include Thermo Fisher Scientific, a provider of various automated cell culture systems and consumables; Sartorius AG, known for its bioprocessing solutions including automated cell culture equipment; Merck KGaA, offering a range of cell culture products designed for automation; GE Healthcare Sciences, which develops technologies for cell therapy manufacturing; and Becton, Dickinson and Company (BD), supplying advanced biotechnology instruments and associated reagents. These companies are among those at the forefront of innovation in the automated cell culture sector, competing to provide solutions that meet the evolving needs of biotechnology research and production. Show Less Read more